New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?

The incidence of liver cancer is continuously rising where hepatocellular carcinoma (HCC) remains the most common form of liver cancer accounting for approximately 80–90% of the cases. HCC is strongly prejudiced by the tumor microenvironment and being an inflammation-associated condition, the contri...

Descripción completa

Detalles Bibliográficos
Autores principales: Khanam, Arshi, Kottilil, Shyam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820509/
https://www.ncbi.nlm.nih.gov/pubmed/36613878
http://dx.doi.org/10.3390/ijms24010437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820509/
https://www.ncbi.nlm.nih.gov/pubmed/36613878
http://dx.doi.org/10.3390/ijms24010437

Ejemplares similares